What Causes Enthesopathy?

Tendinopathy—particularly insertional tendinopathy—is a common overuse injury affecting the junction where tendon inserts into bone. Its pathogenesis is multifactorial, involving both mechanical and biological processes. Repetitive microtrauma from excessive or unaccustomed loading disrupts tendon homeostasis, triggering failed healing responses rather than classic inflammation. Histologically, affected tendons show tendinosis: disorganized collagen architecture, increased non-collagenous matrix, tenocyte dysregulation, and neovascularization—features distinct from acute inflammatory tendinitis.

Biomechanical factors play a central role. Abnormal joint alignment, muscle imbalances, inadequate footwear, or sudden increases in training volume or intensity can elevate mechanical stress at the enthesis—the specialized tendon-to-bone interface. This stress exceeds the tissue’s adaptive capacity, leading to matrix degradation and impaired collagen synthesis. Age-related changes—including reduced vascularity, diminished tenocyte proliferative capacity, and cumulative microdamage—further compromise tendon resilience.

Emerging evidence also implicates metabolic and systemic contributors. Conditions such as obesity, diabetes mellitus, dyslipidemia, and chronic kidney disease are associated with higher incidence and poorer outcomes in tendinopathy. These comorbidities promote oxidative stress, advanced glycation end-product accumulation, and low-grade systemic inflammation—all of which impair tendon metabolism and repair mechanisms.

Genetic predisposition may modulate individual susceptibility. Polymorphisms in genes encoding collagen type V, matrix metalloproteinases (MMPs), and growth factors have been linked to altered tendon structure and increased risk of degenerative tendinopathy. However, no single gene variant is determinative; rather, genetic background interacts with environmental and behavioral exposures to shape clinical phenotype.